Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $4.9 million.

  • Medifast's Other Working Capital Changes rose 22435.13% to $4.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 million, marking a year-over-year increase of 18324.56%. This contributed to the annual value of $2.1 million for FY2025, which is 18324.56% up from last year.
  • Per Medifast's latest filing, its Other Working Capital Changes stood at $4.9 million for Q4 2025, which was up 22435.13% from -$2.2 million recorded in Q3 2025.
  • Over the past 5 years, Medifast's Other Working Capital Changes peaked at $6.6 million during Q1 2022, and registered a low of -$6.6 million during Q1 2023.
  • In the last 5 years, Medifast's Other Working Capital Changes had a median value of $589500.0 in 2021 and averaged $365900.0.
  • As far as peak fluctuations go, Medifast's Other Working Capital Changes skyrocketed by 263885.71% in 2021, and later tumbled by 122420.21% in 2023.
  • Over the past 5 years, Medifast's Other Working Capital Changes (Quarter) stood at $4.8 million in 2021, then tumbled by 207.09% to -$5.1 million in 2022, then soared by 146.39% to $2.4 million in 2023, then plummeted by 36.88% to $1.5 million in 2024, then surged by 224.35% to $4.9 million in 2025.
  • Its Other Working Capital Changes stands at $4.9 million for Q4 2025, versus -$2.2 million for Q3 2025 and -$512000.0 for Q2 2025.